Price (delayed)
$38.03
Market cap
$5.24B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.77
Enterprise value
$4.87B
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing
There are no recent dividends present for ISEE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.